Medicine & Life Sciences
6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one
100%
quinoline
67%
Pharmaceutical Preparations
19%
Glucuronides
12%
Oxides
8%
Tandem Mass Spectrometry
7%
Urine
7%
Liquid Chromatography
7%
High Pressure Liquid Chromatography
5%
Type I DNA Topoisomerase
4%
Type II DNA Topoisomerase
4%
Clinical Trials, Phase I
4%
Drug Delivery Systems
3%
Intravenous Infusions
3%
Hydrolysis
3%
Mass Spectrometry
3%
Parents
2%
Chemical Compounds
Pharmacological Metabolism
36%
N-Oxide
33%
Liquid Chromatography Mass Spectrometry (LCMS)
32%
Mass Spectrum
27%
Drug
24%
Dose
24%
High-Pressure Liquid Chromatography
24%
Mass Spectrometry
21%
Enzymatic Hydrolysis
16%
Retention Time
14%
Amount
6%